PL374280A1 - Soluble drug extended release system - Google Patents

Soluble drug extended release system

Info

Publication number
PL374280A1
PL374280A1 PL02374280A PL37428002A PL374280A1 PL 374280 A1 PL374280 A1 PL 374280A1 PL 02374280 A PL02374280 A PL 02374280A PL 37428002 A PL37428002 A PL 37428002A PL 374280 A1 PL374280 A1 PL 374280A1
Authority
PL
Poland
Prior art keywords
extended release
release system
soluble drug
drug extended
soluble
Prior art date
Application number
PL02374280A
Other languages
English (en)
Polish (pl)
Inventor
Victoria Rogers
Philippe J.M. Dor
Joseph A. Fix
Hiroyuki Kojima
Kazuhiro Sako
Original Assignee
Yamanouchi Pharma Technologies, Inc.
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Technologies, Inc., Astellas Pharma Inc. filed Critical Yamanouchi Pharma Technologies, Inc.
Publication of PL374280A1 publication Critical patent/PL374280A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02374280A 2001-11-13 2002-11-12 Soluble drug extended release system PL374280A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US787701A 2001-11-13 2001-11-13

Publications (1)

Publication Number Publication Date
PL374280A1 true PL374280A1 (en) 2005-10-03

Family

ID=21728577

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02374280A PL374280A1 (en) 2001-11-13 2002-11-12 Soluble drug extended release system

Country Status (10)

Country Link
EP (1) EP1443901A4 (fr)
JP (2) JP4882200B2 (fr)
KR (2) KR101016619B1 (fr)
CN (1) CN100534531C (fr)
AU (1) AU2002348279C1 (fr)
CA (1) CA2466657C (fr)
MX (1) MXPA04004544A (fr)
PL (1) PL374280A1 (fr)
RU (1) RU2322263C2 (fr)
WO (1) WO2003041656A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
JP4822092B2 (ja) * 2003-09-01 2011-11-24 大正製薬株式会社 Ｗ／ｏ／ｗ型複合エマルション
AU2004289221B2 (en) * 2003-11-04 2009-12-17 Supernus Pharmaceuticals, Inc Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
CN102387792B (zh) * 2009-03-25 2013-08-14 琳得科株式会社 固体制剂
KR101319420B1 (ko) * 2011-03-18 2013-10-17 한남대학교 산학협력단 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템
US20140038879A1 (en) * 2011-04-11 2014-02-06 Council Of Scientific & Industrial Research Surface induced disassembly of nano containers
CN102977413B (zh) * 2011-09-07 2015-05-13 江南大学 聚合物复合制备胶束的一种新方法
CN103083222B (zh) * 2011-10-28 2015-08-19 江南大学 一锅法制备三组分聚合物胶束
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
KR20220022829A (ko) * 2020-08-19 2022-02-28 주식회사 모든바이오 글리시리진 및 수용성 약물을 포함하는 나노 입자, 이를 포함하는 약제학적 조성물 및 이들의 제조 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
JPS6410466A (en) * 1987-07-01 1989-01-13 Brother Ind Ltd Data recording and reproducing method for magnetic disk
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
KR100355130B1 (ko) * 1992-09-18 2003-01-30 야마노우치세이야쿠 가부시키가이샤 하이드로겔서방성정제
US5788959A (en) * 1995-04-24 1998-08-04 University Of Maryland, Baltimore County Drug delivery device and method for employing the same
CA2228610C (fr) * 1995-08-17 2008-06-03 Heidi Rolfes Produits a liberation controlee
IT1297461B1 (it) * 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
OA11652A (en) * 1998-09-14 2004-12-08 Ranbaxy Lab Ltd Orally administered controlled drug delivery system providing temporal and spatial control.
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica

Also Published As

Publication number Publication date
WO2003041656A2 (fr) 2003-05-22
JP4882200B2 (ja) 2012-02-22
CN100534531C (zh) 2009-09-02
JP2005508995A (ja) 2005-04-07
JP2011068700A (ja) 2011-04-07
KR20100123779A (ko) 2010-11-24
JP4894958B2 (ja) 2012-03-14
KR101132969B1 (ko) 2012-04-09
AU2002348279C1 (en) 2008-09-04
EP1443901A2 (fr) 2004-08-11
KR101016619B1 (ko) 2011-02-23
CA2466657A1 (fr) 2003-05-22
MXPA04004544A (es) 2005-03-31
EP1443901A4 (fr) 2010-06-16
WO2003041656A3 (fr) 2003-10-23
CA2466657C (fr) 2011-02-01
CN1612726A (zh) 2005-05-04
RU2322263C2 (ru) 2008-04-20
KR20050044424A (ko) 2005-05-12
RU2004117848A (ru) 2005-05-27
AU2002348279B2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
GB2377236B (en) Packer releasing system
EP1383376A4 (fr) Formulations pharmaceutiques a liberation prolongee
HK1062151A1 (en) Cutaneous administration system
HUP0401438A3 (en) Drug delivery system
MXPA03003235A (es) Formulaciones farmaceuticas de liberacion retrasada.
AU2002327068A1 (en) Immediate release tablet
AU2001283359A1 (en) Drug release (delivery system)
HK1077523A1 (en) Proliposomal drug delivery system
EP1411905A4 (fr) Systeme d'administration a liberation prolongee
HUP0104472A3 (en) Sustained release matrix systems for highly soluble drugs
EP1411904A4 (fr) Composition pharmaceutique a liberation prolongee
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
EP1443901A4 (fr) Systeme de liberation prolongee de medicaments solubles
EP1453482A4 (fr) Systeme pharmaceutique radio-opaque a liberation prolongee
IL139177A0 (en) Sustained release drug delivery system
GB0103877D0 (en) Novel Drug Delivery system
GB0029843D0 (en) Drug delivery system
GB0021487D0 (en) Pharmaceutical
GB0325060D0 (en) Drug release system
GB9919664D0 (en) Slow release delivery system
AUPQ985200A0 (en) Slow release pharmaceutical preparation
AU151852S (en) Soluble capsule
AU149726S (en) Soluble capsule
GB0112326D0 (en) Drug delivery system
GB0115136D0 (en) Drug delivery system

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)